Click here to close
Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly.
We suggest using a current version of Chrome,
FireFox, or Safari.
Effects of mutations causing hypokalaemic periodic paralysis on the skeletal muscle L-type Ca2+ channel expressed in Xenopus laevis oocytes.
Morrill JA
,
Cannon SC
.
???displayArticle.abstract???
1. A truncated form of the rabbit alpha1S Ca2+ channel subunit (alpha1SDeltaC) was expressed with the beta1b, alpha2delta and gamma auxiliary subunits in Xenopus laevis oocytes. After 5-7 days, skeletal muscle L-type currents were measured (469 +/- 48 nA in 10 mM Ba2+). All three of the auxiliary subunits were necessary to record significant L-type current. A rapidly inactivating, dihydropyridine-insensitive endogenous Ba2+ current was observed in oocytes expressing the auxiliary subunits without an exogenous alpha subunit. Expression of full-length alpha1S gave 10-fold smaller currents than the truncated form. 2. Three missense mutations causing hypokalaemic periodic paralysis (R528H in domain II S4 of the alpha1S subunit; R1239H and R1239G in domain IV S4) were introduced into alpha1SDeltaC and expressed in oocytes. L-type current was separated from the endogenous current by nimodipine subtraction. All three of the mutations reduced L-type current amplitude ( approximately 40 % for R528H, approximately 60-70 % for R1239H and R1239G). 3. The disease mutations altered the activation properties of L-type current. R528H shifted the G(V) curve approximately 5 mV to the left and modestly reduced the voltage dependence of the activation time constant, tauact. R1239H and R1239G shifted the G(V) curve approximately 5-10 mV to the right and dramatically slowed tauact at depolarized test potentials. 4. The voltage dependence of steady-state inactivation was not significantly altered by any of the disease mutations. 5. Wild-type and mutant L-type currents were also measured in the presence of (-)-Bay K8644, which boosted the amplitude approximately 5- to 7-fold. The effects of the mutations on the position of the G(V) curve and the voltage dependence of tauact were essentially the same as in the absence of agonist. Bay K-enhanced tail currents were slowed by R528H and accelerated by R1239H and R1239G. 6. We conclude that the domain IV mutations R1239H and R1239G have similar effects on the gating properties of the skeletal muscle L-type Ca2+ channel expressed in Xenopus oocytes, while the domain II mutation R528H has distinct effects. This result implies that the location of the substitutions is more important than their degree of conservation in determining their biophysical consequences.
Affolter,
Agonists Bay-K8644 and CGP-28392 open calcium channels reconstituted from skeletal muscle transverse tubules.
1985, Pubmed
Affolter,
Agonists Bay-K8644 and CGP-28392 open calcium channels reconstituted from skeletal muscle transverse tubules.
1985,
Pubmed
Beam,
Function of a truncated dihydropyridine receptor as both voltage sensor and calcium channel.
1992,
Pubmed
Beam,
Calcium currents in embryonic and neonatal mammalian skeletal muscle.
1988,
Pubmed
Cha,
Voltage sensors in domains III and IV, but not I and II, are immobilized by Na+ channel fast inactivation.
1999,
Pubmed
,
Xenbase
Chen,
A unique role for the S4 segment of domain 4 in the inactivation of sodium channels.
1996,
Pubmed
,
Xenbase
Cota,
Calcium-channel gating in frog skeletal muscle membrane: effect of temperature.
1983,
Pubmed
Dascal,
Calcium channel currents in Xenopus oocytes injected with rat skeletal muscle RNA.
1992,
Pubmed
,
Xenbase
De Jongh,
Characterization of the two size forms of the alpha 1 subunit of skeletal muscle L-type calcium channels.
1991,
Pubmed
Delbono,
Calcium current activation and charge movement in denervated mammalian skeletal muscle fibres.
1992,
Pubmed
Dirksen,
Single calcium channel behavior in native skeletal muscle.
1995,
Pubmed
Elbaz,
Hypokalemic periodic paralysis and the dihydropyridine receptor (CACNL1A3): genotype/phenotype correlations for two predominant mutations and evidence for the absence of a founder effect in 16 caucasian families.
1995,
Pubmed
Fontaine,
Mapping of the hypokalaemic periodic paralysis (HypoPP) locus to chromosome 1q31-32 in three European families.
1994,
Pubmed
Fouad,
Genotype-phenotype correlations of DHP receptor alpha 1-subunit gene mutations causing hypokalemic periodic paralysis.
1997,
Pubmed
Francini,
Inactivation of the slow calcium current in twitch skeletal muscle fibres of the frog.
1992,
Pubmed
García,
Ca2+ current and charge movement in adult single human skeletal muscle fibres.
1992,
Pubmed
García,
Role of S4 segments and the leucine heptad motif in the activation of an L-type calcium channel.
1997,
Pubmed
Grabner,
Transfer of 1,4-dihydropyridine sensitivity from L-type to class A (BI) calcium channels.
1996,
Pubmed
Hess,
Calcium channel selectivity for divalent and monovalent cations. Voltage and concentration dependence of single channel current in ventricular heart cells.
1986,
Pubmed
Hofmann,
Molecular basis for Ca2+ channel diversity.
1994,
Pubmed
Johnson,
Modulation of the cloned skeletal muscle L-type Ca2+ channel by anchored cAMP-dependent protein kinase.
1997,
Pubmed
Jurkat-Rott,
A calcium channel mutation causing hypokalemic periodic paralysis.
1994,
Pubmed
Jurkat-Rott,
Calcium currents and transients of native and heterologously expressed mutant skeletal muscle DHP receptor alpha1 subunits (R528H).
1998,
Pubmed
Lacerda,
Normalization of current kinetics by interaction between the alpha 1 and beta subunits of the skeletal muscle dihydropyridine-sensitive Ca2+ channel.
1991,
Pubmed
Lapie,
Electrophysiological properties of the hypokalaemic periodic paralysis mutation (R528H) of the skeletal muscle alpha 1s subunit as expressed in mouse L cells.
1996,
Pubmed
Lerche,
Expression and functional characterization of the cardiac L-type calcium channel carrying a skeletal muscle DHP-receptor mutation causing hypokalaemic periodic paralysis.
1996,
Pubmed
Ma,
Dihydropyridine-sensitive skeletal muscle Ca channels in polarized planar bilayers. 1. Kinetics and voltage dependence of gating.
1991,
Pubmed
Mejía-Alvarez,
Voltage-dependent inactivation of T-tubular skeletal calcium channels in planar lipid bilayers.
1991,
Pubmed
Melzer,
The role of Ca2+ ions in excitation-contraction coupling of skeletal muscle fibres.
1995,
Pubmed
Mitrovic,
Independent versus coupled inactivation in sodium channels. Role of the domain 2 S4 segment.
1998,
Pubmed
Morrill,
Gating of the L-type Ca channel in human skeletal myotubes: an activation defect caused by the hypokalemic periodic paralysis mutation R528H.
1998,
Pubmed
Nakai,
Critical roles of the S3 segment and S3-S4 linker of repeat I in activation of L-type calcium channels.
1994,
Pubmed
Nargeot,
Heterologous expression of calcium channels.
1992,
Pubmed
Pardo,
Extracellular K+ specifically modulates a rat brain K+ channel.
1992,
Pubmed
,
Xenbase
Perez-Reyes,
Induction of calcium currents by the expression of the alpha 1-subunit of the dihydropyridine receptor from skeletal muscle.
1989,
Pubmed
Ptácek,
Dihydropyridine receptor mutations cause hypokalemic periodic paralysis.
1994,
Pubmed
Ren,
Functional expression and characterization of skeletal muscle dihydropyridine receptors in Xenopus oocytes.
1997,
Pubmed
,
Xenbase
Rivet,
A third type of calcium current in cultured human skeletal muscle cells.
1992,
Pubmed
Rüdel,
Hypokalemic periodic paralysis: in vitro investigation of muscle fiber membrane parameters.
1984,
Pubmed
Sánchez,
Kinetic properties of calcium channels of twitch muscle fibres of the frog.
1983,
Pubmed
Schwartz,
Dihydropyridine receptors in muscle are voltage-dependent but most are not functional calcium channels.
,
Pubmed
Sipos,
L-type calcium current activation in cultured human myotubes.
1997,
Pubmed
Sipos,
Skeletal muscle DHP receptor mutations alter calcium currents in human hypokalaemic periodic paralysis myotubes.
1995,
Pubmed
Strube,
Molecular origin of the L-type Ca2+ current of skeletal muscle myotubes selectively deficient in dihydropyridine receptor beta1a subunit.
1998,
Pubmed
Tanabe,
Repeat I of the dihydropyridine receptor is critical in determining calcium channel activation kinetics.
1991,
Pubmed
Tanabe,
Restoration of excitation-contraction coupling and slow calcium current in dysgenic muscle by dihydropyridine receptor complementary DNA.
1988,
Pubmed
Tricarico,
Impairment of skeletal muscle adenosine triphosphate-sensitive K+ channels in patients with hypokalemic periodic paralysis.
1999,
Pubmed
Varadi,
Acceleration of activation and inactivation by the beta subunit of the skeletal muscle calcium channel.
1991,
Pubmed